Evidence map›Paper›PMID 16407408›Full record

ArticleMolecular biology of the cell2006

Survivin modulates microtubule dynamics and nucleation throughout the cell cycle.

Jack Rosa, Pedro Canovas, Ashraful Islam, Dario C Altieri, Stephen J Doxsey

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Tubulin Complexity in Cancer and Metastasis.Advances in experimental medicine and biology · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ran GTPase: A Key Player in Tumor Progression and Metastasis.Frontiers in cell and developmental biology · 2020
    Review
  19. Article
  20. Survivin at a glance.Journal of cell science · 2019
    Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jack RosaProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Pedro Canovas
Ashraful Islam
Dario C Altieri
Stephen J Doxsey
University of Massachusetts Chan Medical School · US

Funding

SUBNUCLEAR TARGETING OF TRANSCRIPTION FACTORSP01CA082834 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, GARY S. · 2001 to 2015
$18.4M
CONTROL OF APOPTOSIS IN CANCER BY SURVIVINR01CA078810 · NCI · YALE UNIVERSITY · PI ALTIERI, DARIO C · 1998 to 2017
$5.5M
Mitotic functions of cilia proteinsR01GM051994 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DOXSEY, STEPHEN J · 1995 to 2014
$4.3M
Molecular Pathology of Vascular InjuryR37HL054131 · NHLBI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2004 to 2013
$3.1M
Molecular Targeting of the Survivin Pathway in CancerR01CA090917 · NCI · YALE UNIVERSITY · PI ALTIERI, DARIO C · 2001 to 2010
$3.0M
MOLECULAR PATHOLOGY OF VASCULAR INJURYR01HL054131 · NHLBI · YALE UNIVERSITY · PI ALTIERI, DARIO C. · 1994 to 2003
$1.0M
Centrosome and mitotic functions of ciliary proteinsR56GM051994 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DOXSEY, STEPHEN J · 2009 to 2009
$375k
NCI NIH HHS CA-78810NCI NIH HHS CA-82834NCI NIH HHS CA-90917NCI NIH HHS P01 CA082834NCI NIH HHS R01 CA078810NCI NIH HHS R01 CA090917NHLBI NIH HHS HL-54131NHLBI NIH HHS R01 HL054131NHLBI NIH HHS R37 HL054131NIGMS NIH HHS GM51994NIGMS NIH HHS R01 GM051994NIGMS NIH HHS R56 GM051994
6 · The paper itself

Abstract

Survivin is a member of the chromosomal passenger complex implicated in kinetochore attachment, bipolar spindle formation, and cytokinesis. However, the mechanism by which survivin modulates these processes is unknown. Here, we show by time-lapse imaging of cells expressing either green fluorescent protein (GFP)-alpha-tubulin or the microtubule plus-end binding protein GFP-EB1 that depletion of survivin by small interfering RNAs (siRNAs) increased both the number of microtubules nucleated by centrosomes and the incidence of microtubule catastrophe, the transition from microtubule growth to shrinking. In contrast, survivin overexpression reduced centrosomal microtubule nucleation and suppressed both microtubule dynamics in mitotic spindles and bidirectional growth of microtubules in midbodies during cytokinesis. siRNA depletion or pharmacologic inhibition of another chromosomal passenger protein Aurora B, had no effect on microtubule dynamics or nucleation in interphase or mitotic cells even though mitosis was impaired. We propose a model in which survivin modulates several mitotic events, including spindle and interphase microtubule organization, the spindle assembly checkpoint and cytokinesis through its ability to modulate microtubule nucleation and dynamics. This pathway may affect the microtubule-dependent generation of aneuploidy and defects in cell polarity in cancer cells, where survivin is commonly up-regulated.

Indexed as

Cell CycleAnimalsAurora Kinase BAurora KinasesCells, CulturedCentrosomeChlorocebus aethiopsCOS CellsCytokinesisHumansInhibitor of Apoptosis ProteinsInterphaseMicrotubule-Associated ProteinsMicrotubulesMitosisNeoplasm ProteinsAURKB protein, humanAurora Kinase BAurora KinasesBIRC5 protein, humanInhibitor of Apoptosis ProteinsMicrotubule-Associated ProteinsNeoplasm ProteinsProtein Serine-Threonine KinasesRecombinant Fusion ProteinsSurvivin

Identifiers

PMID16407408
PMCPMC1382334
OpenAlexW2117582353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.